First Stage Investor

Q&A With 20/20 GeneSystems

Q&A With 20/20 GeneSystems
By Andy Gordon
Date February 15, 2018
Share
Today, we’re bringing you a fascinating conversation we had with Jonathan Cohen, the founder and CEO of our recently recommended company 20/20 GeneSystems. 20/20 focuses on reducing cancer mortality worldwide through early detection. It has pioneered a novel approach of continuous machine learning using large data sets…
Early Investing

First Stage Investor

Sign up to view this First Stage Investor article

Become a smarter investor! Discover new investment opportunities and get the latest market research, trends and analysis in startups, crypto and cannabis.

Top Posts on Early Investing